After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Recently, Yahoo Finance discussed the stock, revealing that FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
FibroGen Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $2.64 and fluctuated between $2.7899 as its day high and $2.5500 as its day low. The current market capitalization of FibroGen Inc is $260.75M. A total of 1.63 million shares were traded on the day, compared to an average of 2.62M shares.
In the most recent transaction, Wettig Thane bought 50,000 shares of FGEN for 1.91 per share on Mar 07 ’24. After the transaction, the CEO now owns 470,178 company shares. In a previous transaction on Sep 01 ’23, Henderson Jeffrey William sold 2,000 shares at 1.03 per share. FGEN shares that Director owns now total 28,866.
Among the insiders who sold shares, Henderson Jeffrey William disposed of 2,000 shares on Aug 04 ’23 at a per-share price of $1.91. This resulted in the Director holding 30,866 shares of FGEN after the transaction. In another insider transaction, Henderson Jeffrey William sold 2,000 shares at $2.69 per share on Jul 11 ’23. Company shares held by the Director now total 32,866.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, FGEN has a high of $20.90 and a low of $0.33.
As of this writing, FGEN has an earnings estimate of -$0.41 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.52. The company reported an EPS of -$0.65 in the last quarter, which was 4.40% higher than expectations of -$0.68.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. FGEN’s latest balance sheet shows that the firm has $405.19M in Cash & Short Term Investments as of fiscal 2021. There were $99.72M in debt and $225.50M in liabilities at the time. Its Book Value Per Share was -$2.07, while its Total Shareholder’s Equity was $229.11M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FGEN is Buy with a score of 2.00.
